Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry

Affiliations

• ¹ Department of Hematology, Kawasaki Medical School, Kurashiki, Japan.
• ² Department of Oncology/Hematology, Shimane University Hospital, Izumo, Japan.
• ³ Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kokura, Japan.
• ⁴ Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
• ⁵ Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
• ⁶ Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
• ⁷ Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
• ⁸ Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
• ⁹ Division of Hematology and Oncology, Iwate Medical University, Iwate, Japan.
• ¹⁰ Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
• ¹¹ Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo, Japan.
• ¹² Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan.
• ¹³ Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
• ¹⁴ Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
• ¹⁵ Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
• ¹⁶ Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagoya, Japan.
• ¹⁷ Department of Hematology, Kawasaki Medical School, Kurashiki, Japan. eisei-k@med.kawasaki-m.ac.jp.